Discover
TMCI
Treace Medical Concepts, Inc.
4.23
2 x 3.08
2 x 5.10
bid
ask
+
0.25
6.28%
2 @ 04:00 PM
4.35 +0.12 (2.84%)
| Ytd | 72.65% | |
| 1y | -30.54% |
3.94
day range
4.30
1.17
52 week range
7.78
| Open | 3.94 | Prev Close | 3.98 | Low | 3.94 | High | 4.30 | Mkt Cap | 274.41M |
| Vol | 493.36K | Avg Vol | 923.19K | EPS | -0.96 | P/E | N/A | Forward P/E | -9.28 |
| Beta | 0.24 | Short Ratio | 3.26 | Inst. Own | 64.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.04 | 200-d Avg | 3.28 | 1yr Est | 7.96 |
| Income Statement | |||
| Total Revenue | 47.20M | ||
| Revenues (USD) | 47.20M | ||
| Cost of Revenue | 9.79M | ||
| Gross Profit | 37.41M | ||
| Operating Expenses | 54.57M | ||
| Research and Development Expense | 4.62M | ||
| Selling, General and Administrative Expense | 49.95M | ||
| Operating Income | -17.17M | ||
| Interest Expense | 1.57M | ||
| Net Income | -17.96M | ||
| Net Income Common Stock | -17.96M | ||
| Net Income Common Stock (USD) | -17.96M | ||
| Consolidated Income | -17.96M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -16.39M | ||
| Earning Before Interest & Taxes (USD) | -16.39M | ||
| Weighted Average Shares | 64.59M | ||
| Weighted Average Shares Diluted | 64.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.54M | ||
| Cash and Equivalents (USD) | 9.54M | ||
| Investments | 42.31M | ||
| Investments Current | 42.31M | ||
| Trade and Non-Trade Receivables | 30.36M | ||
| Current Assets | 123.47M | ||
| Property, Plant & Equipment Net | 39.43M | ||
| Total Assets | 184.10M | ||
| Total Debt | 69.37M | ||
| Current Liabilities | 34.49M | ||
| Debt Non-Current | 69.37M | ||
| Total Liabilities | 106.91M | ||
| Accumulated Retained Earnings (Deficit) | -266.95M | ||
| Accumulated Other Comprehensive Income | -26.00K | ||
| Shareholders Equity | 77.19M | ||
| Shareholders Equity (USD) | 77.19M | ||
| Assets Non-Current | 60.63M | ||
| Total Debt (USD) | 69.37M | ||
| Goodwill and Intangible Assets | 19.70M | ||
| Inventory | 36.37M | ||
| Liabilities Non-Current | 72.42M | ||
| Trade and Non-Trade Payables | 13.54M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.47M | ||
| Net Cash Flow from Financing | -588.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.16M | ||
| Capital Expenditure | -3.06M | ||
| Issuance (Purchase) of Equity Shares | 91.00K | ||
| Issuance (Repayment) of Debt Securities | -472.00K | ||
| Net Cash Flow from Investing | -7.82M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -4.75M | ||
| Net Cash Flow from Operations | 7.24M | ||
| Share Based Compensation | 8.03M | ||